Nasal Spray Could Delay Alzheimer's by Years
An anti-Alzheimer's nasal spray that could delay the progress of the disease by years has been developed by scientists at ...
Investor's Business Daily on MSN1d
ARS Pharma Jumps After Inking $145 Million Deal For Epinephrine Nasal Spray
ARS Pharmaceuticals shares jumped Monday after the company inked a deal to commercialize its allergic reaction nasal spray internationally.
pulmonologyadvisor1d
Tezspire Reduces Nasal Congestion and Polyp Size in Chronic Rhinosinusitis
Results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and congestion in CRSwNP.
FiercePharma1d
With US launch progressing, ARS inks another licensing deal for epinephrine spray Neffy worth up to $465M
Although ARS Pharmaceuticals’ approval for its epinephrine nasal spray came later than expected, the company ultimately received a thumbs up from the FDA in August and is now moving fast to expand ...
CNET2d
Which Decongestants Are Effective? Why the FDA Wants to Pull a Popular Medicine Ingredient
Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its ...